{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:26:36Z","timestamp":1789068396602,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canep.2025.102976","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T04:11:40Z","timestamp":1765512700000},"page":"102976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Etiologic profile and prognostic patterns of hepatocellular carcinoma in a Southern European population \u2013 Madeira, Portugal: Insight into a preventable cancer"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-2938","authenticated-orcid":false,"given":"Pedro H.","family":"Berenguer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Serr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5456-3290","authenticated-orcid":false,"given":"Carolina","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4779-5765","authenticated-orcid":false,"given":"Laurentina","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4765-7271","authenticated-orcid":false,"given":"Nuno","family":"Ladeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8502-835X","authenticated-orcid":false,"given":"Paulo S.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clinic."},{"issue":"10125","key":"10.1016\/j.canep.2025.102976_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.canep.2025.102976_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","article-title":"Liver cancer in 2021: Global Burden of Disease study","volume":"82","author":"Tan","year":"2025","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.canep.2025.102976_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.canep.2025.102976_bib5","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.canep.2025.102976_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.canep.2025.102976_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77515-y","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cgh.2023.08.016","article-title":"Incidence of etiology-specific hepatocellular carcinoma: diverging trends and significant heterogeneity by race and ethnicity","volume":"22","author":"Pinheiro","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.2208","article-title":"Liver cancer etiology in Asian subgroups and American Indian, black, Latino, and white populations","volume":"8","author":"Pinheiro","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"3-4","key":"10.1016\/j.canep.2025.102976_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/lci2.77","article-title":"Geographic and temporal trends in aetiology, incidence and mortality from hepatocellular carcinoma in European Union 15+ countries","volume":"4","author":"Hanbury","year":"2023","journal-title":"Liver Cancer Int."},{"issue":"10","key":"10.1016\/j.canep.2025.102976_bib11","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/liv.15357","article-title":"Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.canep.2025.102976_bib12","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canep.2025.102976_bib13","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2147\/JHC.S420603","article-title":"Updates in characteristics and survival rates of hepatocellular carcinoma in a Nationwide Cohort of Real-World US Patients, 2003-2021","volume":"10","author":"Tran","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"12","key":"10.1016\/j.canep.2025.102976_bib14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1055-9965.EPI-24-0626","article-title":"Hepatocellular carcinoma etiology drives survival outcomes: a population-based analysis","volume":"33","author":"Cranford","year":"2024","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.canep.2025.102976_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.diii.2023.01.002","article-title":"Life expectancy of patients with hepatocellular carcinoma according to the upfront treatment: a nationwide analysis","volume":"104","author":"Cassinotto","year":"2023","journal-title":"Diagn. Interv. Imaging"},{"issue":"9","key":"10.1016\/j.canep.2025.102976_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35066","article-title":"Survival outcomes among patients with hepatocellular carcinoma in a large integrated US Health System","volume":"7","author":"Yilma","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canep.2025.102976_bib17","unstructured":"Regional Directorate of Statistics of Madeira (DREM), In 2023, the hospitals in the Autonomous Region of Madeira recorded a 17.2% increase in outpatient appointments conducted in hospital outpatient units, 2024. \u3008https:\/\/estatistica.madeira.gov.pt\/en\/download-now-3\/social-gb\/saude-gb\/2015-11-11-16-36-24\/saude-noticias-gb\/4913-13-12-2024-hospitais.html\u3009. (Accessed 12-11-2025)."},{"key":"10.1016\/j.canep.2025.102976_bib18","unstructured":"Regional Directorate of Statistics of Madeira (DREM), Censos 2021 resultados definitivos - Regi\u00e3o Aut\u00f3noma da Madeira, 2023. \u3008https:\/\/estatistica.madeira.gov.pt\/index.php\u3009. (Accessed 15-04-2025)."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2019.05.008","article-title":"Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification","volume":"71","author":"Ioannou","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cgh.2022.03.010","article-title":"Clinical characteristics and outcomes of nonalcoholic fatty liver disease-associated hepatocellular carcinoma in the United States","volume":"21","author":"Karim","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.canep.2025.102976_bib21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013","volume":"149","author":"Beste","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.canep.2025.102976_bib22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.canep.2025.102976_bib23","unstructured":"GBD - Global Burden of Disease Collaborative Network, Global Burden of Disease study 2021 (GBD 2021) results, 2022. \u3008https:\/\/vizhub.healthdata.org\/gbd-results\/\u3009. (Accessed 15-04-2025)."},{"key":"10.1016\/j.canep.2025.102976_bib24","unstructured":"M. Segi, Kk Nippon Taigan, I. T\u014dhoku Daigaku, Cancer mortality for selected sites in 24 countries, Cancer mortality for selected sites in 24 countries. (1950)."},{"key":"10.1016\/j.canep.2025.102976_bib25","series-title":"a technical report","author":"Cancer incidence in five continents","year":"1966"},{"key":"10.1016\/j.canep.2025.102976_bib26","unstructured":"INE, Instituto Nacional de Estat\u00edstica\/ Statistics Portugal, 2025. \u3008https:\/\/www.ine.pt\/\u3009. (Accessed 15-03-2025)."},{"issue":"20","key":"10.1016\/j.canep.2025.102976_bib27","first-page":"1","article-title":"Age adjustment using the 2000 projected U.S. population","author":"Klein","year":"2001","journal-title":"Healthy People 2010 Stat. Notes"},{"issue":"15","key":"10.1016\/j.canep.2025.102976_bib28","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2025.102976_bib29","unstructured":"IBM Corp, IBM SPSS Statistics for Windows, version 22.0, Armonk, NY, 2013."},{"key":"10.1016\/j.canep.2025.102976_bib30","series-title":"Regulation (EU) 2016\/679 (General Data Protection Regulation), 02016R0679-20160504","first-page":"1","author":"European Parliament and Council","year":"2016"},{"key":"10.1016\/j.canep.2025.102976_bib31","unstructured":"RON, Registo oncol\u00f3gico nacional de todos os tumores na popula\u00e7\u00e3o residente em Portugal, em 2021, Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil - EPE, Porto, Portugal, 2024."},{"key":"10.1016\/j.canep.2025.102976_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.canep.2025.102976_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biology12070984","article-title":"Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma","volume":"12","author":"Nevola","year":"2023","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/biochem5030019","article-title":"HCC in MASLD and ALD: Biochemical pathways, epidemiology, diagnosis, and treatment","volume":"5","author":"Patel","year":"2025","journal-title":"BioChem"},{"issue":"10003","key":"10.1016\/j.canep.2025.102976_bib35","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2025.102976_bib36","author":"WHO","year":"2025","journal-title":"WHO\/UNICEF Estim. Natl. Immun. Cover."},{"issue":"1","key":"10.1016\/j.canep.2025.102976_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12879-023-08433-3","article-title":"Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study","volume":"23","author":"Trickey","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"22","key":"10.1016\/j.canep.2025.102976_bib38","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3748\/wjg.v27.i22.2994","article-title":"Hepatocellular carcinoma in viral and autoimmune liver diseases: role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment","volume":"27","author":"Granito","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canep.2025.102976_bib39","series-title":"United States, August 2021\u2013August 2023","author":"Obesity and severe obesity prevalence in adults","year":"2024"},{"issue":"8","key":"10.1016\/j.canep.2025.102976_bib40","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/liv.13371","article-title":"Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years","volume":"37","author":"Ascione","year":"2017","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.canep.2025.102976_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.45525","article-title":"Trends in hepatocellular carcinoma mortality rates in the US and projections through 2040","volume":"7","author":"Qiu","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.canep.2025.102976_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","article-title":"Hepatocellular carcinoma surveillance \u2014 utilization, barriers and the impact of changing aetiology","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.canep.2025.102976_bib43","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/hep4.1564","article-title":"Hepatocellular carcinoma survival by etiology: a SEER-medicare database analysis","volume":"4","author":"Brar","year":"2020","journal-title":"Hepatol. Commun."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.13485","article-title":"Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome","volume":"43","author":"Bucci","year":"2016","journal-title":"Aliment Pharm. Ther."},{"issue":"2","key":"10.1016\/j.canep.2025.102976_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/liv.13204","article-title":"The evolutionary scenario of hepatocellular carcinoma in Italy: an update","volume":"37","author":"Bucci","year":"2017","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.canep.2025.102976_bib46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1634\/theoncologist.2012-0066","article-title":"Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies","volume":"17","author":"Wang","year":"2012","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.canep.2025.102976_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","article-title":"Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer","volume":"6","author":"Kichenadasse","year":"2020","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.canep.2025.102976_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3945\/ajcn.116.136531","article-title":"Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer12","volume":"104","author":"Walter","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.canep.2025.102976_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36968-7","article-title":"Obesity paradox as a new insight from postoperative complications in gastric cancer","volume":"13","author":"Kamiya","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3520","article-title":"Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis","volume":"4","author":"Petrelli","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.canep.2025.102976_bib51","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1186\/s12885-020-07651-1","article-title":"The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.canep.2025.102976_bib52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1515\/oncologie-2025-0025","article-title":"Impact of body mass index in patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors","volume":"27","author":"Wang","year":"2025","journal-title":"Oncologie"},{"issue":"37","key":"10.1016\/j.canep.2025.102976_bib53","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3748\/wjg.v30.i37.4132","article-title":"Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy","volume":"30","author":"Wang","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.canep.2025.102976_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3164\/jcbn.10-149","article-title":"Increased levels of serum leptin are a risk factor for the recurrence of stage I\/II hepatocellular carcinoma after curative treatment","volume":"49","author":"Watanabe","year":"2011","journal-title":"J. Clin. Biochem Nutr."},{"issue":"9","key":"10.1016\/j.canep.2025.102976_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The obesity paradox in cancer: a review","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.canep.2025.102976_bib56","article-title":"Alcohol and hepatocellular carcinoma","volume":"6","author":"Hiroshi","year":"2019","journal-title":"BMJ Open Gastroenterol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212500236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212500236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:16:19Z","timestamp":1771431379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778212500236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S187778212500236X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102976","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiologic profile and prognostic patterns of hepatocellular carcinoma in a Southern European population \u2013 Madeira, Portugal: Insight into a preventable cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102976"}}